PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Almost 50% of patients under 60 years choose TAVR over surgical aortic valve replacement with worse outcomes

2024-01-28
(Press-News.org) Despite national guidelines recommending surgical aortic valve replacement (SAVR) for patients under age 65 with severe aortic stenosis, many hospitals are still opting for a nonsurgical approach in patients under 60—possibly with poorer survival rates.

In a study presented at The Society of Thoracic Surgeons’ 2024 Annual Meeting in San Antonio, Texas, researchers from the department of cardiac surgery in the Smidt Heart Institute at Cedars-Sinai in Los Angeles and the department of population health science and policy at Mount Sinai New York compared outcomes for patients undergoing surgery and those undergoing nonsurgical or transcatheter aortic valve replacement (TAVR) from 2013 to 2021 in California.

From a pool of 37,011 patients, the study identified 2,360 patients under the age of 60 years who underwent these procedures, with 22% receiving TAVR and 78% SAVR. By 2021 almost half of patients younger than 60 years were receiving TAVR rather than SAVR.  The research team followed these patients for a median time of 2.4 years after TAVR and 4.9 years after SAVR to assess their outcomes.

The primary focus was on 5-year survival rates. Secondary outcomes included rates of reoperation, infective endocarditis, stroke, and hospital admissions for heart failure. Propensity score matching ensured a fair comparison of 358 pairs of patients, balancing factors such as age, major health conditions, hospital volume, and urgency.

While the 30-day mortality rates were similar (0.2% for SAVR vs. 0.4% for TAVR), the 5-year survival rate was significantly better after surgery compared to TAVR (98% vs. 86%, p < 0.001). For secondary outcomes, there was no significant difference between the two groups.

“While we expected that the volume of transcatheter therapy would increase over the study period in this young patient cohort, we were surprised there appears to be near equipoise in terms of procedure selection, with patients and clinicians opting for procedures against the 2020 guidelines,” said study coauthor Jad Malas, MD, a cardiothoracic surgery resident at Cedars-Sinai Medical Center in Los Angeles.

In their 2020 consensus guidelines, the American College of Cardiology and the American Hospital Association recommended surgery over TAVR in patients under 65 with severe aortic stenosis, a condition that stiffens and narrows the aortic valve, making blood flow more difficult. Dr. Malas and colleagues wanted a real-world snapshot of how hospitals are treating patients in an even younger cohort.

The study results indicate a need for randomized trials in younger patients (who represent fewer than 10% of the patients in randomized trials comparing these treatments)—as well as more balanced and informed patient-centered decision-making—to support more appropriate practice in this younger patient population, said Dr. Joanna Chikwe, senior author of the study and chair of the department of cardiac surgery in the Smidt Heart Institute at Cedars-Sinai. She added that her research group has expanded their analysis to include a multi-state registry for better comparison of the two procedures.

“As cardiac surgeons, we owe it to our patients to take a more prominent role in providing the highest quality evidence to help our patients make these major healthcare decisions,” she emphasized. “While transcatheter therapy appears more attractive to most patients, there are clearly long-term benefits with surgical therapy for the lifetime management of valvular heart disease in many patients.”

# # #

Media contact: Kathy Cummings, Society of Thoracic Surgeons, kcummings@sts.org

Founded in 1964, The Society of Thoracic Surgeons is a not-for-profit organization representing more than 7,700 cardiothoracic surgeons, researchers, and allied healthcare professionals worldwide who are dedicated to ensuring the best possible outcomes for surgeries of the heart, lung, and esophagus, as well as other surgical procedures within the chest. The Society’s mission is to enhance the ability of cardiothoracic surgeons to provide the highest quality patient care through education, research, and advocacy.

END



ELSE PRESS RELEASES FROM THIS DATE:

New study reveals the profound impact of forced separation between humans and their pets

2024-01-28
Pet owners forced to be separated from their animals in crisis situations, including those who are victims of domestic violence, are suffering from a lack of support services needed to protect them. These are the findings of a new review of 27 years of international research, published in the peer-reviewed journal Anthrozoös, which unveils the increased risks to both safety and psychological well-being when people are faced with the threat of forced separation from their pets. The results provide important insights towards addressing the challenges arising from domestic violence, homelessness or natural disasters that can threaten the bond between humans and ...

Immunotherapy post-surgery improves overall survival for kidney cancer

2024-01-27
Boston – For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer. Treatment with pembrolizumab, an immunotherapy drug, after surgery significantly prolonged overall survival in patients with clear-cell renal-cell carcinoma (ccRCC) at high risk for recurrence, according to an analysis of results from the KEYNOTE-564 study. Pembrolizumab was associated with a 38% reduction in risk of death compared with placebo. “We can now ...

STS announces late-breaker research to be presented at the 2024 Annual Meeting

2024-01-27
The Society of Thoracic Surgeons has released late-breaking research scheduled for presentation at the 2024 Annual Meeting taking place January 27 - 29 in San Antonio. The conference, healthcare’s leading scientific and educational convening specializing in cardiothoracic surgery, has a rich history of showcasing clinical trials with a strong foundation of detailed methodology and trusted data collection governed by ethical clinical principles. The event’s late-breaking trial sessions focus on studies anticipated to significantly influence advances in cardiothoracic patient care. In this fast-paced healthcare landscape, ...

Breakthrough research identifies predictors of venous thromboembolism after pulmonary resection for lung cancer

2024-01-27
A new study presented at The Society of Thoracic Surgeons’ 2024 Annual Meeting in San Antonio, Texas, examines the ongoing controversy surrounding the choice between multi-arterial grafting (MAG) and single arterial grafting (SAG) in coronary artery bypass grafting (CABG) for multivessel coronary revascularization. The research, spanning from 2008 to 2019 and involving over one million patients undergoing isolated CABG with more than two bypass grafts, found that multi-arterial grafting CABG ...

To stick or not to stick? Mixed sand columns illuminate design of better materials

To stick or not to stick? Mixed sand columns illuminate design of better materials
2024-01-27
Tokyo, Japan – Scientists from Tokyo Metropolitan University have been studying the strength and toughness of sand columns made of a mixture of sticky and non-sticky grains. They have uncovered the mechanism behind how the strength changes as grains are mixed in different ratios, and how a mixture can help keep the column more resilient to deformation. Non-sticky grains are also easily replaceable with other materials, enabling the design of stronger, tougher, functional matter.   Granular matter consists of vast numbers of small grains, like sand and powders. Such grains can be made to stick to each other, yielding strong materials ...

Huntsman Cancer Institute receives $20 million land donation from Flagship Companies and Woodbury Corporation, the developers of Utah City

Huntsman Cancer Institute receives $20 million land donation from Flagship Companies and Woodbury Corporation, the developers of Utah City
2024-01-27
Huntsman Cancer Institute at the University of Utah (the U) has received a $20 million land donation from the developers of Utah City, a new walkable mixed-use city center. This significant contribution from Woodbury Corporation and Flagship Companies, in partnership with the City of Vineyard, will pave the way for the establishment of the state-of-the-art Huntsman Cancer Institute campus in Utah County. Huntsman Cancer Institute is the National Cancer Institute-designated Comprehensive Cancer Center for Utah, Idaho, ...

EPB, ORNL announce plans for research collaborative focused on energy resilience, quantum technology

EPB, ORNL announce plans for research collaborative focused on energy resilience, quantum technology
2024-01-26
Building on $180 million in joint energy-related research, EPB and Oak Ridge National Laboratory (ORNL) marked 10 years of collaboration Friday with the announcement of the new Collaborative for Energy Resilience and Quantum Science (CERQS). The new joint research effort will focus on utilizing Chattanooga’s highly advanced and integrated energy and communications infrastructure to develop technologies and best practices for enhancing the resilience and security of the national power grid while accelerating the commercialization of quantum technologies.  U.S. Representative Chuck Fleischmann (TN-03), ...

UT awarded $2.8 million DOE Grant to modernize the nation’s electric power grid

2024-01-26
Validating its status as a leader in power electronics for grid and aviation applications, the University of Tennessee has been awarded a grant from the Advanced Research Projects Agency-Energy (ARPA-E) of the US Department of Energy (DOE) to help modernize the nation’s power grid. ARPA-E is distributing $42 million for 15 projects across 11 states to improve the reliability, resiliency, and flexibility of the domestic power grid through the development of next-generation semiconductor technologies. Funded through ARPA-E’s Unlocking Lasting Transformative Resiliency Advances by Faster Actuation of power ...

Flame-retardant chemicals may increase risk of preterm birth, higher birth weight

2024-01-26
Pregnant women exposed to specific classes of flame-retardant chemicals may face an increased risk of preterm birth, especially for baby girls, or higher birth weights, according to a Rutgers Health researcher. Emily Barrett, professor and vice chair of the Department of Biostatistics and Epidemiology at the Rutgers School of Public Health and a member of the Rutgers Environmental and Occupational Health Sciences Institute, took part in a study that was published in Environmental Health Perspectives and funded by the Environmental influences on Child Health Outcomes (ECHO) Program at the National Institutes of Health. Manufacturers commonly use organophosphate esters (OPEs) ...

A long-lasting neural probe

2024-01-26
Recording the activity of large populations of single neurons in the brain over long periods of time is crucial to further our understanding of neural circuits, to enable novel medical device-based therapies and, in the future, for brain–computer interfaces requiring high-resolution electrophysiological information. But today there is a tradeoff between how much high-resolution information an implanted device can measure and how long it can maintain recording or stimulation performances. Rigid, silicon ...

LAST 30 PRESS RELEASES:

How sound moves on Mars

Increasing plant diversity in agricultural grasslands boosts yields, reducing reliance on fertilizer

Scientists uncover a new role for DNA loops in repairing genetic damage

AI chatbots can effectively sway voters – in either direction

Study reveals 'levers' driving the political persuasiveness of AI chatbots

'Tiny' tyrannosaurid, Nanotyrannus lancensis, was a distinctive species, not juvenile T. Rex

Scientists capture first detailed look inside droplet-like structures of compacted DNA

Return of the short (tyrant) king: A new paper by Dinosaur Institute researcher shows Nanotyrannus was not a juvenile T. Rex

New study confirms Nanotyrannus holotype was distinct species from T. rex

Carnegie Science names Michael Blanton 12th Observatories Director

From mice to humans in five years: Microglia replacement paving the way for neurodegenerative disease therapies

To treat long COVID, we must learn from historical chronic illnesses, medical researchers say

Volcanic eruptions set off a chain of events that brought the Black Death to Europe

Environmental science: Volcanic activity may have brought the Black Death to medieval Europe

Public trust in scientists for cancer information across political ideologies in the US

Adverse experiences, protective factors, and obesity in Latinx and Hispanic youths

Researchers identify bacterial enzyme that can cause fatal heart conditions with pneumonia infections

Single enzyme failure found to drive neuron loss in dementia

Sudden cardiac death risk falls in colorectal cancer, but disparities persist

From lab to clinic: CU Anschutz launches Phase 1 clinical trial of promising combination therapy for resistant ovarian cancer

Renuka Iyer, MD, named new Chief Medical Officer for National Comprehensive Cancer Network (NCCN)

New organ-on-a-chip platform allows the testing of cancer vaccine efficacy in aging populations

No, we don't need more and more data about nature. We need more people to use the data

Research explores effect of parental depression symptoms on children’s reward processing

Phonetic or morpholexical issues? New study reveals L2 French ambiguity

Seeing inside smart gels: scientists capture dynamic behavior under stress

Korea University researchers create hydrogel platform for high-throughput extracellular vesicle isolation

Pusan National University researchers identify the brain enzyme that drives nicotine addiction and smoking dependence

Pathway discovered to make the most common breast cancer tumor responsive to immunotherapy

Air pollution linked to more severe heart disease

[Press-News.org] Almost 50% of patients under 60 years choose TAVR over surgical aortic valve replacement with worse outcomes